Living-donor single-lobe lung transplantation for pulmonary hypertension due to alveolar capillary dysplasia with misalignment of pulmonary veins.
clinical research/practice
donors and donation: living
lung transplantation/pulmonology
lung transplantation: living donor
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
19
11
2019
revised:
11
12
2019
accepted:
19
12
2019
pubmed:
29
12
2019
medline:
22
6
2021
entrez:
29
12
2019
Statut:
ppublish
Résumé
This is a case report of a successful single-lobe lung transplantation for pulmonary hypertension secondary to alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV). A 6-year-old boy underwent living-donor single-lobe transplantation with the right lower lobe from his 31-year-old mother. The pretransplantation graft size matching was acceptable: the estimated graft forced vital capacity (FVC) was 96.5% of the recipient's predicted FVC, and the graft size measured by computed tomography (CT) volumetry was 166% of the recipient's chest cavity volume. Right pneumonectomy followed by implantation was performed under cardiopulmonary bypass (CPB). The pulmonary arterial pressure was significantly decreased to 31/12 mm Hg immediately after transplantation, and the first PaO
Identifiants
pubmed: 31883304
doi: 10.1111/ajt.15762
pii: S1600-6135(22)22373-9
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1739-1743Informations de copyright
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons.
Références
Starnes VA, Barr ML, Cohen RG. Lobar transplantation. Indications, technique, and outcome. J Thorac Cardiovasc Surg. 1994;108(3):403-410; discussion 410-1.
Woo MS, MacLaughlin EF, Horn MV, et al. Living donor lobar lung transplantation: the pediatric experience. Pediatr Transplant. 1998;2(3):185-190.
Date H, Aoe M, Nagahiro I, et al. Living-donor lobar lung transplantation for various lung diseases. J Thorac Cardiovasc Surg. 2003;126(2):476-481.
Date H, Shiraishi T, Sugimoto S, et al. Outcome of living-donor lobar lung transplantation using a single donor. J Thorac Cardiovasc Surg. 2012;144(3):710-715.
Date H, Aoyama A, Hijiya K, et al. Outcomes of various transplant procedures (single, sparing, inverted) in living-donor lobar lung transplantation. J Thorac Cardiovasc Surg. 2017;153(2):479-486.
Date H, Sano Y, Aoe M, et al. Living-donor single-lobe lung transplantation for primary pulmonary hypertension in a child. J Thorac Cardiovasc Surg. 2002;123(6):1211-1213.
Toyooka S, Sano Y, Yamane M, et al. Long-term follow-up of living-donor single lobe transplantation for idiopathic pulmonary arterial hypertension in a child. J Thorac Cardiovasc Surg. 2008;135(2):451-452.
Bishop NB, Stankiewicz P, Steinhorn RH. Alveolar capillary dysplasia. Am J Respir Crit Care Med. 2011;184(2):172-179.
Towe CT, White FV, Grady RM, et al. Infants with atypical presentations of alveolar capillary dysplasia with misalignment of the pulmonary veins who underwent bilateral lung transplantation. J Pediatr. 2018;194:158-164.
Sato M, Okada Y, Oto T, et al. Registry of the Japanese Society of Lung and Heart-Lung Transplantation: official Japanese lung transplantation report, 2014. Gen Thorac Cardiovasc Surg. 2014;62(10):594-601.
Chen F, Kubo T, Yamada T, et al. Adaptation over a wide range of donor graft lung size discrepancies in living-donor lobar lung transplantation. Am J Transplant. 2013;13(5):1336-1342.
Date H, Sato M, Aoyama A, et al. Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patients†. Eur J Cardio-Thoracic Surg. 2015;47(6):967-973.
Dierickx D, Habermann TM. post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018;378(6):549-562.
Zimmermann H, Trappe RU. Therapeutic options in post-transplant lymphoproliferative disorders. Ther Adv Hematol. 2011;2(6):393-407.
Neuringer IP. Posttransplant lymphoproliferative disease after lung transplantation. Clin Dev Immunol. 2013;2013:1-11.
Leyssens A, Dierickx D, Verbeken EK, et al. Post-transplant lymphoproliferative disease in lung transplantation: a nested case-control study. Clin Transplant. 2017;31(7):e12983.
Paranjothi S, Yusen RD, Kraus MD, Lynch JP, Patterson GA, Trulock EP. Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases. J Heart Lung Transplant. 2001;20(10):1054-1063.
Raj R, Frost AE. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients. J Hear Lung Transplant. 2005;24(6):671-679.